Literature DB >> 26063920

Spinocerebellar ataxia type 6 protein aggregates cause deficits in motor learning and cerebellar plasticity.

Melanie D Mark1, Martin Krause2, Henk-Jan Boele3, Wolfgang Kruse2, Stefan Pollok2, Thomas Kuner4, Deniz Dalkara5, Sebastiaan Koekkoek3, Chris I De Zeeuw6, Stefan Herlitze2.   

Abstract

Spinocerebellar ataxia type 6 (SCA6) is linked to poly-glutamine (polyQ) within the C terminus (CT) of the pore-forming subunits of P/Q-type Ca(2+) channels (Cav2.1) and is characterized by CT protein aggregates found in cerebellar Purkinje cells (PCs). One hypothesis regarding SCA6 disease is that a CT fragment of the Cav2.1 channel, which is detected specifically in cytosolic and nuclear fractions in SCA6 patients, is associated with the SCA6 pathogenesis. To test this hypothesis, we expressed P/Q-type channel protein fragments from two different human CT splice variants, as predicted from SCA6 patients, in PCs of mice using viral and transgenic approaches. These splice variants represent a short (CT-short without polyQs) and a long (CT-long with 27 polyQs) CT fragment. Our results show that the different splice variants of the CTs differentially distribute within PCs, i.e., the short CTs reveal predominantly nuclear inclusions, whereas the long CTs prominently reveal both nuclear and cytoplasmic aggregates. Postnatal expression of CTs in PCs in mice reveals that only CT-long causes SCA6-like symptoms, i.e., deficits in eyeblink conditioning (EBC), ataxia, and PC degeneration. The physiological phenotypes associated specifically with the long CT fragment can be explained by an impairment of LTD and LTP at the parallel fiber-to-PC synapse and alteration in spontaneous PC activity. Thus, our results suggest that the polyQ carrying the CT fragment of the P/Q-type channel is sufficient to cause SCA6 pathogenesis in mice and identifies EBC as a new diagnostic strategy to evaluate Ca(2+) channel-mediated human diseases.
Copyright © 2015 the authors 0270-6474/15/358882-14$15.00/0.

Entities:  

Keywords:  P/Q type calcium channel; poly-glutamine disease; spinocerebellar ataxia type 6

Mesh:

Substances:

Year:  2015        PMID: 26063920      PMCID: PMC6605201          DOI: 10.1523/JNEUROSCI.0891-15.2015

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  36 in total

Review 1.  Using the shared genetics of dystonia and ataxia to unravel their pathogenesis.

Authors:  Esther A R Nibbeling; Cathérine C S Delnooz; Tom J de Koning; Richard J Sinke; Hyder A Jinnah; Marina A J Tijssen; Dineke S Verbeek
Journal:  Neurosci Biobehav Rev       Date:  2017-01-28       Impact factor: 8.989

2.  Control of voluntary and optogenetically perturbed locomotion by spike rate and timing of neurons of the mouse cerebellar nuclei.

Authors:  Rashmi Sarnaik; Indira M Raman
Journal:  Elife       Date:  2018-04-16       Impact factor: 8.140

Review 3.  Depressed by Learning-Heterogeneity of the Plasticity Rules at Parallel Fiber Synapses onto Purkinje Cells.

Authors:  Aparna Suvrathan; Jennifer L Raymond
Journal:  Cerebellum       Date:  2018-12       Impact factor: 3.847

4.  Bicistronic CACNA1A Gene Expression in Neurons Derived from Spinocerebellar Ataxia Type 6 Patient-Induced Pluripotent Stem Cells.

Authors:  Carlo Bavassano; Andreas Eigentler; Ruslan Stanika; Gerald J Obermair; Sylvia Boesch; Georg Dechant; Roxana Nat
Journal:  Stem Cells Dev       Date:  2017-10-30       Impact factor: 3.272

5.  Protein kinase C activity is a protective modifier of Purkinje neuron degeneration in cerebellar ataxia.

Authors:  Ravi Chopra; Aaron H Wasserman; Stefan M Pulst; Chris I De Zeeuw; Vikram G Shakkottai
Journal:  Hum Mol Genet       Date:  2018-04-15       Impact factor: 6.150

6.  In vivo analysis of cerebellar Purkinje cell activity in SCA2 transgenic mouse model.

Authors:  Polina A Egorova; Olga A Zakharova; Olga L Vlasova; Ilya B Bezprozvanny
Journal:  J Neurophysiol       Date:  2016-03-16       Impact factor: 2.714

7.  Altered synaptic and firing properties of cerebellar Purkinje cells in a mouse model of ARSACS.

Authors:  Visou Ady; Brenda Toscano-Márquez; Moushumi Nath; Philip K Chang; Jeanette Hui; Anna Cook; François Charron; Roxanne Larivière; Bernard Brais; R Anne McKinney; Alanna J Watt
Journal:  J Physiol       Date:  2018-07-19       Impact factor: 5.182

8.  Cerebellar Purkinje cells control eye movements with a rapid rate code that is invariant to spike irregularity.

Authors:  Hannah L Payne; Ranran L French; Christine C Guo; Td Barbara Nguyen-Vu; Tiina Manninen; Jennifer L Raymond
Journal:  Elife       Date:  2019-05-03       Impact factor: 8.140

9.  Oligonucleotide therapy mitigates disease in spinocerebellar ataxia type 3 mice.

Authors:  Hayley S McLoughlin; Lauren R Moore; Ravi Chopra; Robert Komlo; Megan McKenzie; Kate G Blumenstein; Hien Zhao; Holly B Kordasiewicz; Vikram G Shakkottai; Henry L Paulson
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

Review 10.  Cellular and circuit mechanisms underlying spinocerebellar ataxias.

Authors:  Pratap Meera; Stefan M Pulst; Thomas S Otis
Journal:  J Physiol       Date:  2016-06-12       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.